These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7643882)

  • 1. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
    Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA
    N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
    Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
    N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.
    Mehta SR; Eikelboom JW; Rupprecht HJ; Lewis BS; Natarajan MK; Yi C; Pogue J; Yusuf S
    Eur Heart J; 2002 Jan; 23(2):117-23. PubMed ID: 11785993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
    N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group.
    Verin V; Popowski Y; de Bruyne B; Baumgart D; Sauerwein W; Lins M; Kovacs G; Thomas M; Calman F; Disco C; Serruys PW; Wijns W;
    N Engl J Med; 2001 Jan; 344(4):243-9. PubMed ID: 11172150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
    Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
    Savage MP; Douglas JS; Fischman DL; Pepine CJ; King SB; Werner JA; Bailey SR; Overlie PA; Fenton SH; Brinker JA; Leon MB; Goldberg S
    N Engl J Med; 1997 Sep; 337(11):740-7. PubMed ID: 9287229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary angioplasty in unstable angina at rest. Influence of the degree of clinical instability on the immediate and long-term results].
    Cavallini C; Olivari Z; Risica G; Cannarozzo PP; Marton F; Grisolia EF; Giommi L; Stritoni P
    G Ital Cardiol; 1996 Jun; 26(6):647-55. PubMed ID: 8803586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
    O'Neill WW; Serruys P; Knudtson M; van Es GA; Timmis GC; van der Zwaan C; Kleiman J; Gong J; Roecker EB; Dreiling R; Alexander J; Anders R
    N Engl J Med; 2000 May; 342(18):1316-24. PubMed ID: 10793164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
    Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
    J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty.
    Unterberg C; Sandrock D; Nebendahl K; Buchwald AB
    J Am Coll Cardiol; 1995 Dec; 26(7):1747-54. PubMed ID: 7594113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
    N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study.
    Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P
    Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of unstable angina after the discontinuation of heparin.
    Théroux P; Waters D; Lam J; Juneau M; McCans J
    N Engl J Med; 1992 Jul; 327(3):141-5. PubMed ID: 1608405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.